Can hepatitis B vaccination enhance immune response in all patients with chronic liver disease?
✍ Scribed by F. Özgenç; B. Dikici; R. V. Yagci
- Book ID
- 108603632
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 33 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
De novo hepatitis B infection after liver transplantation, in spite of its low prevalence as found by Fabia et al, 1 is of major concern, especially for infected patients and their families. More follow-up time is needed to assess the real impact in morbidity, mortality, and economic costs. Althoug
Fifty children with malignant diseases were vaccinated against hepatitis B. Twenty-nine children suffered from leukaemia or non-Hodgkin's lymphoma; 14 of these were on intensive chemotherapy (group I) and 15 were without intensive therapy (group II). The other 21 children had various forms of solid